VitaSpring Biomedical Co. Ltd.
Balance Sheet
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $2.1K | $0 | $0 | $29.7K | $107.2K | $45.4K | $0 | $105 |
| Accounts Receivable | — | $0 | $0 | $380.0K | $3.0M | — | — | — |
| Inventory | — | — | — | $0 | $0 | $144.0K | — | — |
| Total Current Assets | $10.5K | $272 | $23.6K | $437.1K | $3.1M | $189.4K | $0 | $10.0K |
| Property, Plant & Equipment | $4.1K | $14.1K | $24.1K | $49.6K | $64.6K | — | — | $1.4K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $14.7K | $14.4K | $137.3K | $765.9K | $3.6M | $189.4K | $0 | $0 |
| Liabilities | ||||||||
| Accounts Payable | $2.4M | $2.4M | $2.4M | $2.4M | $1.3M | $0 | $0 | $0 |
| Total Current Liabilities | $4.4M | $4.0M | $3.5M | $3.1M | $1.7M | $93.0K | $0 | $18.4K |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $4.4M | $4.0M | $3.5M | $3.2M | $2.0M | $93.0K | $0 | $11.4K |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-5.7M | $5.3M | $-4.5M | $-3.4M | $776.4K | $447.3K | $-21.9K | — |
| Total Stockholders' Equity | $-4.4M | $-4.0M | $-3.4M | $-2.4M | $1.6M | $96.4K | — | $-6.9K |